Overview

Intracoronary Bolus Only Compared With Intravenous Bolus and 12-hours Infusion of Abciximab in Non-ST Elevation Myocardial Infarction.

Status:
Unknown status

Trial end date:
2010-12-01

Target enrollment:

Participant gender:

Summary

Intracoronary bolus Abciximab single is non-inferior to intravenous and continuous 12- hours infusion in the size reduction of infarction on cardiac magnetic resonance in Non-ST elevation Myocardial infarction.

Phase:

Phase 4

Details

Lead Sponsor:

Seoul National University Hospital

Collaborator:

Seoul National University Bundang Hospital

Treatments:

Abciximab
Antibodies, Monoclonal
Immunoglobulin Fab Fragments
Krestin
polysaccharide-K